NCT04056819View on ClinicalTrials.gov

Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells in Acute Myocardial Infarction

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

May 27, 2019

Primary Completion Date

August 2, 2021

Study Completion Date

December 17, 2021

Conditions
Acute Myocardial Infarction
Interventions
BIOLOGICAL

Allogeneic umbilical cord mesenchymal stem cells

UMSC01 cells will be one single IC infusion followed by one single IV infusion with 12 months of follow up after treatment.

Trial Locations (1)

404

China Medical University Hospital, Taichung

All Listed Sponsors
lead

Ever Supreme Bio Technology Co., Ltd.

INDUSTRY

NCT04056819 - Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells in Acute Myocardial Infarction | Biotech Hunter | Biotech Hunter